News

The risk of cancer goes up with age, in part because aging impedes the body's ability to detect and destroy cells with ...
A don from the Department of Biochemistry of Covenant University (CU), Prof Solomon Rotimi, is making giant strides in breast cancer research. The academic research paper published in the ...
Scientists could reshape cancer treatment by helping powerful drugs work better in the body by exploiting a surface protein called CD36 that helps pull substances into cells. This dramatically ...
In 2021, research led by Ryan Flynn, MD, PhD, and his mentor, Nobel laureate Carolyn Bertozzi, PhD, opened a new chapter in biology, characterizing a new kind of player on the cell surface: glycoRNAs.
made a major breakthrough with the potential to turn IV drugs into oral treatments for diseases like brain cancer and Alzheimer's disease. The discovery could reshape how medicines are designed ...
Breakthrough research could make any IV drug able to be taken orally for a range of hard-to-treat cancers and other diseases, and redefine how medicines are designed, evaluated and delivered.
and raise hope for a way to refine use of oral SERDS. It's worth noting that the EMERALD trial of Radius/Menarini's elacestrant in HR-positive, HER2-negative breast cancer showed a 30% reduction ...
Lorrie Morgan fans are sending prayers her way this week after it was announced that she has cancelled all of her concerts for the next two weeks to be with her ailing husband. Morgan, who has ...
AstraZeneca could become the first company to bring an oral selective oestrogen receptor degrader (SERD) drug to market as a first-line treatment for breast cancer after camizestrant hit the mark ...